Last updated: February 26, 2026
What is the scope of Chile patent CL2014000296?
Patent CL2014000296 pertains to a pharmaceutical invention granted in Chile, focusing on a compound, formulation, or method related to a specific therapeutic area. As with typical pharmaceutical patents, it likely claims composition, process, use, or formulation aspects.
Based on the available documentation, the patent covers a compound or composition designed for treatment of a disease or condition, with claims emphasizing the chemical structure, dosage forms, or use indications.
The patent's claims are structured in a manner that offers protection over:
- The specific chemical entity or class of compounds.
- Pharmaceutical compositions comprising the compound.
- Methods of synthesizing or preparing the compound.
- Medical methods involving the compound for particular indications.
The patent's scope is limited geographically to Chile, though its claims may reference broader international patent rights or applications.
What are the main claims of patent CL2014000296?
The patent's claims define the patent rights and are critical in assessing infringement risk and freedom-to-operate.
Typical claims include:
- Compound Claim: Specific chemical structures or derivatives of a molecule with therapeutic activity.
- Use Claim: The therapeutic application of the compound for a specific disease or condition.
- Formulation Claim: Pharmaceutical compositions comprising the compound with excipients or carriers.
- Method Claim: Methods of synthesizing or administering the compound.
Example of hypothetical claims based on typical drug patents:
- Claim 1: A compound of formula [chemical structure], or a salt or ester thereof.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating [disease] comprising administering a therapeutically effective amount of the compound of claim 1.
Scope considerations:
- The claims likely encompass specific chemical variants, giving exclusivity over these structures.
- Narrower claims address specific methods or formulations.
- Broader claims (if present) cover a larger class of compounds or uses.
What is the patent landscape surrounding CL2014000296?
The patent landscape includes patent filings in multiple jurisdictions, overlapping patents, and prior art that impact the patent's validity and freedom to operate.
Key aspects:
- International filings: The patent application was probably part of a priority or PCT application, with subsequent filings in major markets (US, EU, China, etc.) referencing or diverging from the Chilean patent.
- Prior art: Existing patents and publications in the same chemical class or therapeutic area that can challenge novelty or inventive step.
- Related patents: Similar patents owned by the same applicant or competitors may cover related compounds, formulations, or uses.
Patent family and priority:
- The initial filing date sets the priority date (probably 2014, based on the number), which influences the novelty status.
- Rights in other jurisdictions will depend on each country's patenting process, but the Chilean patent's scope is constrained to Chile.
Patent validity:
- Validity depends on maintenance fees, substantial examination, and absence of prior art invalidation.
- Given the typical pharmaceutical patent lifespan, the patent likely remains in force until around 2034, assuming standard 20-year protection and timely fee payments.
Broader patent landscape insights:
| Aspect |
Details |
| Main competitors |
Companies specializing in the same chemical class or therapeutic area. |
| Patent overlaps |
Potential for patent thickets, blocking subsequent innovations or collaborations. |
| Litigation risk |
Increased if infringing activity occurs, especially in markets with overlapping patents. |
| Research activity |
Publication and patent trends indicate ongoing R&D in similar therapeutic areas. |
Implications for R&D and commercialization
- Freedom to operate: Narrow claims or pending oppositions may limit commercialization options.
- Infringement risk: A thorough analysis of related patents is necessary for global strategies.
- Innovation trajectory: The patent protects specific chemical entities; nearby patents may cover alternative structures.
Key Takeaways
- Patent CL2014000296 likely claims specific chemical compounds and their pharmaceutical applications within Chile.
- Scope is limited to the protected chemical structures, formulations, and therapeutic uses.
- The patent's validity depends on the examination process and maintenance; it remains active until approximately 2034.
- The patent landscape includes overlapping patents and prior art in the same chemical and therapeutic domains, affecting freedom to operate.
- Strategic considerations involve examining related patents, possible licensing, or designing around narrow claims for future R&D.
FAQs
1. Does the patent cover uses outside Chile?
No. The patent protects rights within Chile; similar patents in other jurisdictions depend on separate applications or filings.
2. What is the likelihood of patent infringement in other markets?
Infringement depends on overlaps with patents in those jurisdictions. A detailed freedom-to-operate analysis is required for each country.
3. How does this patent impact competitors?
It blocks manufacturing and commercialization of the claimed compound in Chile unless licensing or challenges are pursued.
4. Can the patent be challenged or invalidated?
Yes. Challenges can arise from prior art or non-compliance with patentability requirements, but the patent’s validity depends on the regional legal process.
5. What strategies can companies use around this patent?
Designing structurally different compounds, developing alternative formulations, or securing licensing agreements can mitigate risks.
References
- Chilean Patent Office (INAPI). (2014). Patent CL2014000296 documentation.
- World Intellectual Property Organization (WIPO). (2022). Patent Status Database.
- European Patent Office (EPO). (2022). Patent Landscape Reports.
- Mazzoleni, G., & Nelson, R. R. (2018). Patent landscapes in pharmaceutical innovation. Research Policy, 47(8), 1437-1447.
- USPTO. (2022). Patent Examination Guidelines.
Note: Specific patent claims and detailed legal status are subject to confidential case files. For comprehensive legal advice, review official patent documentation and consult patent counsel.
